相关实验视频

Updated: Jul 1, 2025

Author Spotlight: Exploring the Impact of Trauma on Cellular Aging

Author Spotlight: Exploring the Impact of Trauma on Cellular Aging

Published on: March 22, 2024

基因决定的端粒长度作为血液恶性瘤的危险因素:来自孟德尔随机分析的证据

Tian Fang¹, Zhihao Zhang², Kexing Ren¹

¹Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

|March 7, 2024

概括

这项研究显示,较长的端粒长度与各种血液性恶性瘤 (包括淋巴瘤和白血病) 的风险增加之间存在显著联系. 然而,反向关系没有得到支持.

科学领域:

遗传学是一个遗传学.
在瘤学瘤学.
流行病学流行病学

背景情况:

端粒长度和血液性恶性瘤之间的确切关系仍然不完全理解.
端粒长度是一个已知的生物标志物,与细胞衰老和癌症风险有关.

研究的目的:

为了研究基因预测的端粒长度与发展血液恶性瘤的风险之间的潜在因果关系.
为了澄清端粒长度与这些癌症之间的双向关联.

主要方法:

采用了一个双样本的门德尔随机化研究设计.
与端粒长度相关的遗传变异被用作仪器变量.
淋巴细胞和造血性恶性瘤的数据来自FinnGen R9数据库.
反变量加权 (IVW) 分析是主要的统计方法,加权中位数,MR-Egger和MRPRESSO用于灵敏度分析.

主要成果:

在基因预测较长的端粒长度和原发性淋巴瘤 (OR=1.52),霍奇金淋巴瘤 (OR=1.64),非霍奇金淋巴瘤 (OR=1.70),B细胞淋巴瘤 (OR=1.57),非状淋巴瘤 (OR=1.58),地幔细胞淋巴瘤 (OR=3.13),淋巴白血病 (OR=2.56),急性淋巴细胞白血病 (OR=2.65),慢性淋巴细胞白血病 (OR=2.80) 和多发性骨髓瘤 (OR=1.85) 的风险增加之间发现了显著的积极联系.
没有显著的证据表明淋巴瘤或其他造血性恶性瘤因果影响端粒长度.

结论:

基因预测较长的端粒长度因果相关,与发展广泛的血液性恶性瘤的风险增加有关.
这些发现表明端粒长度可能是这些癌症的危险因素,而不是后果.

关键词:

门德尔的随机化这种因果关系是因果关系.血液形成性恶性瘤淋巴瘤淋巴瘤是什么端粒的长度端粒的长度

更多相关视频

Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence

Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence

Published on: May 22, 2013

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

相关概念视频

Replicative Cell Senescence

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...

Telomeres and Telomerase

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Replication in Eukaryotes

Replication in Eukaryotes

In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...